葛兰素史克斥资1750万美元收购CAMP4调控RNA协议
GSK pays $17.5M for CAMP4 regulatory RNA deal
生物技术与制药领域的最新动态
GSK pays $17.5M for CAMP4 regulatory RNA deal
Takeda looks to 2026 FDA filing for its Sotyktu rival zasocitinib after phase 3 success
Lilly's obesity pill largely maintains weight lost on injectable GLP-1s
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
Takeda's $4B immunology drug achieves first Phase 3 successes
Subcutaneous Rybrevant; Kalaris shares nAMD data; Pyxis disappoints
Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World E - PharmiWeb.com
Lilly scores again in weight loss with daily GLP-1 orforglipron
Alnylam, INCOG and Novartis expand in US; Ember gets $16.5M Series A
Takeda says $4B TYK2 drug succeeds in large psoriasis studies
“It can’t wait until tomorrow”: How patient advocacy drives change - Illumina
Recent discoveries on the acquisition of the highest levels of human performance | Science
AQP5: A functional gastric cancer stem cell marker in mouse and human tumors | Science
Ancient genomes illuminate the origins and dynamic history of East Asian cattle | Science
Conformational landscape adaptations enable processive phosphorylation by Src family kinases | Science
Optimal perovskite vapor partitioning on textured silicon for high-stability tandem solar cells | Science
Identification of intestinal enteroendocrine cell subtypes and their associated hormones in zebrafish
Post-transcriptional suppression of the pioneer factor Zelda protects the adult Drosophila testis from activation of the ovary program
The master virulence regulator PhoP dictates carbon metabolism by controlling cyclic AMP synthesis in Salmonella
Paralogs of Slitrk cell adhesion molecules configure excitatory synapse specificity via distinct cellular mechanisms